AI CARDIOVASCULAR PRECISION TOOL TO ADDRESS GLOBAL TIMEBOMB WINS SCI CONTEST
LONDON, March 18, 2022 /PRNewswire/ -- A precision medicine platform with data at its centre has won this year's annual SCI Bright SCIdea competition. CardiaTec, the winning University of Cambridge alumni team, was presented with the award at the SCI (Society of Chemical Industry) offices this week. The team, consisting of co-founders Raphael Peralta, Thelma Zablocki and Namshik Han, explained to the judges how their drug discovery tool can help fight the global problem of 17.8 million deaths a year from cardiovascular disease. At present in the UK, only £9 per person goes to cardiovascular research and development, one third the investment in oncology. CardiaTec's next generation therapeutic model should help redress this imbalance.
- LONDON, March 18, 2022 /PRNewswire/ -- A precision medicine platform with data at its centre has won this year's annual SCI Bright SCIdea competition.
- CardiaTec, the winning University of Cambridge alumni team, was presented with the award at the SCI (Society of Chemical Industry) offices this week.
- SCI is also a global innovation hub so I was delighted to see young scientists from around the world use the event for networking and collaboration."
- SCI works across crucial sectors as diverse as food and bio-renewables, water, environment, energy, materials and manufacturing, and health and wellbeing.